Abstract P5-15-07: First and further line choices of treatment for HER2-VE metastatic breast cancer (MBC) according to adjuvant treatment and biological subtype. Preliminary results of the observational “GIM-13 – AMBRA” Italian studyGiorgio Mustacchi, Anna Turletti, ME Cazzaniga et al.|Cancer Research|2017Cited by 0
Abstract P4-13-04: Not presentedME Cazzaniga, Giorgio Mustacchi, Ornella Garrone et al.|Cancer Research|2019Cited by 0